-
1
-
-
0027941194
-
Human papillomavirus vaccines: A warty problem
-
Galloway DA. Human papillomavirus vaccines: a warty problem. Infect Agents Dis 1994;3:187-93.
-
(1994)
Infect Agents Dis
, vol.3
, pp. 187-193
-
-
Galloway, D.A.1
-
2
-
-
0025886714
-
Human papillomaviruses in the pathogenesis of anogenital cancer
-
zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
-
(1991)
Virology
, vol.184
, pp. 9-13
-
-
Zur Hausen, H.1
-
3
-
-
0024459020
-
Heterogeneity of the human papillomavirus group
-
DeVilliers EM. Heterogeneity of the human papillomavirus group. J Virol 1989;63:4898-903.
-
(1989)
J Virol
, vol.63
, pp. 4898-4903
-
-
DeVilliers, E.M.1
-
4
-
-
0028300962
-
Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids
-
Hagensee ME, Olson NH, Baker TS, Galloway DA. Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J Virol 1994;68:4503-5.
-
(1994)
J Virol
, vol.68
, pp. 4503-4505
-
-
Hagensee, M.E.1
Olson, N.H.2
Baker, T.S.3
Galloway, D.A.4
-
5
-
-
0027930718
-
Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titers of neutralizing antibodies
-
Christensen ND, Hopfl R, DiAngelo S, et al. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titers of neutralizing antibodies. J Gen Virol 1994;75: 2271-6.
-
(1994)
J Gen Virol
, vol.75
, pp. 2271-2276
-
-
Christensen, N.D.1
Hopfl, R.2
Diangelo, S.3
-
6
-
-
0027176291
-
Cottontail rabbit papillomavirus L1 protein-based vaccines: Protection is achieved only with a full-length, nondenatured product
-
Lin YL, Borenstein LA, Ahmed R, Wettstein FO. Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product. J Virol 1993;678:4154-62.
-
(1993)
J Virol
, vol.678
, pp. 4154-4162
-
-
Lin, Y.L.1
Borenstein, L.A.2
Ahmed, R.3
Wettstein, F.O.4
-
7
-
-
0027411456
-
Heterologous protection against influenza by injection of DNA encoding a viral protein
-
Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-9.
-
(1993)
Science
, vol.259
, pp. 1745-1749
-
-
Ulmer, J.B.1
Donnelly, J.J.2
Parker, S.E.3
-
8
-
-
0029051152
-
Pre-clinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus
-
Donnelly JJ, Friedman A, Martinez D, et al. Pre-clinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nature Med 1995;1:583-7.
-
(1995)
Nature Med
, vol.1
, pp. 583-587
-
-
Donnelly, J.J.1
Friedman, A.2
Martinez, D.3
-
9
-
-
0028235445
-
Colocalization of human papillomavirus type 11 E1 E4 and L1 proteins in human foreskin implants grown in athymic mice
-
Brown DR, Fan L, Jones J, Bryan J. Colocalization of human papillomavirus type 11 E1 E4 and L1 proteins in human foreskin implants grown in athymic mice. Virology 1994;201:46-54.
-
(1994)
Virology
, vol.201
, pp. 46-54
-
-
Brown, D.R.1
Fan, L.2
Jones, J.3
Bryan, J.4
-
10
-
-
0027369829
-
DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody
-
Davis, HL, Michel ML, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 1993;2:1847-51.
-
(1993)
Hum Mol Genet
, vol.2
, pp. 1847-1851
-
-
Davis, H.L.1
Michel, M.L.2
Whalen, R.G.3
|